NCM
PPH icon

Niemann Capital Management’s VanEck Pharmaceutical ETF PPH Stock Holding History

Niemann Capital Management’s Portfolio PPH Stock Details PPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-11,750
Closed -$831K – 21
2015
Q2 		$831K Sell
11,750
-525
-4% -$37.8K 0.59% 19
2015
Q1 		$862K Sell
12,275
-712
-5% -$48.3K 0.58% 20
2014
Q4 		$835K Sell
12,987
-114,870
-90% -$7.32M 0.59% 18
2014
Q3 		$8.13M Buy
127,857
+7,007
+6% +$434K 5.83% 8
2014
Q2 		$7.5M Buy
+120,850
New +$7.18M 5.12% 8

Other funds holding PPH

Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
RJA
Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return
MIM
Macroview Investment Management Bethesda, Maryland $162M AUM 22.52% 1-Year Est. Return
AHS
Aspiriant Holdings S3 Los Angeles, California $233M AUM 3.13% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Niemann Capital Management's PPH Position: Q3 2015 in Review

Niemann Capital Management sold out of VanEck Pharmaceutical ETF (PPH) in Q3 2015, closing a stake of 11,750 shares — an estimated $831K sold.

Niemann Capital Management first reported a position in PPH in Q2 2014 and held it in 5 quarters. The position peaked at $8.13M in Q3 2014. 60 funds tracked by Wall St. Rank hold PPH as of Q3 2015.

  • Niemann Capital Management reported no remaining VanEck Pharmaceutical ETF position as of Q3 2015 after selling out during the quarter.
  • Niemann Capital Management sold 11,750 VanEck Pharmaceutical ETF shares in Q3 2015, an estimated $831K.
  • Niemann Capital Management first reported a position in VanEck Pharmaceutical ETF in Q2 2014 and held it in 5 quarters.
  • Niemann Capital Management's VanEck Pharmaceutical ETF position peaked at $8.13M in Q3 2014.
  • 60 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q3 2015.

Based on Niemann Capital Management's 13F filing for Q3 2015, filed 9 Nov 2015.